Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Seminars in Immunopathology
Erschienen in: Seminars in Immunopathology 2/2017

25.11.2016 | Review

The origin of DCs and capacity for immunologic tolerance in central and peripheral tissues

verfasst von: K . Sanjana P. Devi, Niroshana Anandasabapathy

Erschienen in: Seminars in Immunopathology | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Dendritic cells (DCs) are specialized immune sentinels that play key role in maintaining immune homeostasis by efficiently regulating the delicate balance between protective immunity and tolerance to self. Although DCs respond to maturation signals present in the surrounding milieu, multiple layers of suppression also co-exist that reduce the infringement of tolerance against self-antigens. These tolerance inducing properties of DCs are governed by their origin and a range of other factors including distribution, cytokines, growth factors, and transcriptional programing, that collectively impart suppressive functions to these cells. DCs directing tolerance secrete anti-inflammatory cytokines and induce naïve T cells or B cells to differentiate into regulatory T cells (Tregs) or B cells. In this review, we provide a detailed outlook on the molecular mechanisms that induce functional specialization to govern central or peripheral tolerance. The tolerance-inducing nature of DCs can be exploited to overcome autoimmunity and rejection in graft transplantation.
Literatur
1.
2.
3.
4.
Banchereau J, Briere F, Caux C et al (2000) Immunobiology of dendritic cells. Annu Rev Immunol 18:767–811PubMedCrossRef
5.
6.
Forster R, Schubel A, Breitfeld D et al (1999) CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 99:23–33PubMedCrossRef
7.
Martín-Fontecha A, Sebastiani S, Höpken UE et al (2003) Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming. J Exp Med 198:615–621PubMedPubMedCentralCrossRef
8.
Ohl L, Mohaupt M, Czeloth N et al (2004) CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. Immunity 21:279–288PubMedCrossRef
9.
10.
Lutz MB, Schuler G (2002) Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol 23:445–449PubMedCrossRef
11.
Baratin M, Foray C, Demaria O et al (2015) Homeostatic NF-κβ signaling in steady-state migratory dendritic cells regulates immune homeostasis and tolerance. Immunity 42:627–639PubMedCrossRef
12.
Nirschl CJ, Anandasabapathy N (2016) Duality at the gate: skin dendritic cells as mediators of vaccine immunity and tolerance. Hum Vaccines Immunother 12:104–116CrossRef
13.
Dalod M, Chelbi R, Malissen B, Lawrence T (2014) Dendritic cell maturation: functional specialization through signaling specificity and transcriptional programming. EMBO J 33:1104–1116PubMedPubMedCentralCrossRef
14.
15.
Cools N, Ponsaerts P, Van Tendeloo VFI, Berneman ZN (2007) Balancing between immunity and tolerance: an interplay between dendritic cells, regulatory T cells, and effector T cells. J Leukoc Biol 82:1365–1374PubMedCrossRef
16.
Hill M, Cuturi MC (2010) Negative vaccination by tolerogenic dendritic cells in organ transplantation. Curr Opin Organ Transplant 15:738–743PubMedCrossRef
17.
Steinman RM, Hawiger D, Nussenzweig MC (2003) Tolerogenic dendritic cells. Annu Rev Immunol 21:685–711PubMedCrossRef
18.
19.
Morelli AE, Thomson AW (2007) Tolerogenic dendritic cells and the quest for transplant tolerance. Nat Rev Immunol 7:610–621PubMedCrossRef
20.
Mendieta-Zerón H (2011) Developing immunologic tolerance for transplantation at the fetal stage. Immunotherapy 3:1499–1512PubMedCrossRef
21.
22.
Chopin M, Nutt SL (2014) Establishing and maintaining the Langerhans cell network. Semin Cell Dev Biol 41:1–7
23.
24.
Tamoutounour S, Guilliams M, MontananaSanchis F et al (2013) Origins and functional specialization of macrophages and of conventional and monocyte-derived dendritic cells in mouse skin. Immunity 39:925–938PubMedCrossRef
25.
Merad M, Ginhoux F, Collin M (2008) Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells. Nat Rev Immunol 8:935–947PubMedCrossRef
26.
Shortman K, Naik SH (2007) Steady-state and inflammatory dendritic-cell development. Nat Rev Immunol 7:19–30PubMedCrossRef
27.
Cella M, Jarrossay D, Facchetti F et al (1999) Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med 5:919–923PubMedCrossRef
28.
Naik SH, Metcalf D, van Nieuwenhuijze A et al (2006) Intrasplenic steady-state dendritic cell precursors that are distinct from monocytes. Nat Immunol 7:663–671PubMedCrossRef
29.
Guilliams M, Ginhoux F, Jakubzick C et al (2014) Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny. Nat Rev Immunol 14:571–578PubMedPubMedCentralCrossRef
30.
31.
MartIn-Fontecha A, Sebastiani S, Höpken UE et al (2003) Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming. J Exp Med 198:615–621PubMedPubMedCentralCrossRef
32.
Saeki H, Moore AM, Brown MJ, Hwang ST (1999) Cutting edge: secondary lymphoid-tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes. J Immunol 162:2472–2475PubMed
33.
34.
Valladeau J, Ravel O, Dezutter-Dambuyant C et al (2000) Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity 12:71–81PubMedCrossRef
35.
Kaplan DH, Igyártó BZ, Gaspari AA (2012) Early immune events in the induction of allergic contact dermatitis. Nat Rev Immunol 12:114–124PubMedPubMedCentral
36.
37.
Nizza ST, Campbell JJ (2014) CD11b + Migratory dendritic cells mediate CD8 T cell cross-priming and cutaneous imprinting after topical immunization. PLoS One 9:e91054PubMedPubMedCentralCrossRef
38.
Clausen BE, Stoitzner P (2015) Functional specialization of skin dendritic cell subsets in regulating T cell responses. Front Immunol 6:1–19CrossRef
39.
Igyártá BZ, Haley K, Ortner D et al (2011) Skin-resident murine dendritic cell subsets promote distinct and opposing antigen-specific T helper responses. Immunity 35:260–272PubMedCentralCrossRef
40.
Hunger RE, Sieling PA, Ochoa MT et al (2004) Langerhans cells utilize CD1a and langerin to efficiently present nonpeptide antigens to T cells. J Clin Invest 113:701–708PubMedPubMedCentralCrossRef
41.
De Jong A, Cheng T, Huang S et al (2014) CD1a-autoreactive T cells recognize natural skin oils that function as headless antigens. Nat Imunol 15:177–185CrossRef
42.
Anandasabapathy N, Feder R, Mollah S et al (2014) Classical Flt3L-dependent dendritic cells control immunity to protein vaccine. J Exp Med 211:1875–1891PubMedPubMedCentralCrossRef
43.
Mollah SA, Dobrin JS, Feder RE et al (2014) Flt3L dependence helps define an uncharacterized subset of murine cutaneous dendritic cells. J Invest Dermatol 134:1265–1275PubMedCrossRef
44.
Henri S, Poulin LF, Tamoutounour S et al (2010) CD207+ CD103+ dermal dendritic cells cross-present keratinocyte-derived antigens irrespective of the presence of Langerhans cells. J Exp Med 207:189–206PubMedPubMedCentralCrossRef
45.
Tussiwand R, Everts B, Grajales-Reyes GE et al (2015) Klf4 expression in conventional dendritic cells is required for T helper 2 cell responses. Immunity 42:916–928PubMedPubMedCentralCrossRef
46.
Schlitzer A, McGovern N, Teo P et al (2013) IRF4 transcription factor-dependent CD11b + dendritic cells in human and mouse control mucosal IL-17 cytokine responses. Immunity 38:970–983PubMedPubMedCentralCrossRef
47.
Nakano H, Free ME, Whitehead GS et al (2012) Pulmonary CD103+ dendritic cells prime Th2 responses to inhaled allergens. Mucosal Immunol 5:53–65PubMedCrossRef
48.
Henri S, Vremec D, Kamath A et al (2001) The dendritic cell populations of mouse lymph nodes. J Immunol 167:741–748PubMedCrossRef
49.
Borkowski TA, Nelson AJ, Farr AG, Udey MC (1996) Expression of gp40, the murine homologue of human epithelial cell adhesion molecule (ep-CAM), by murine dendritic cells. Eur J Immunol 26:110–114PubMedCrossRef
50.
Nagao K, Ginhoux F, Leitner WW et al (2009) Murine epidermal Langerhans cells and langerin-expressing dermal dendritic cells are unrelated and exhibit distinct functions. Proc Natl Acad Sci U S A 106:3312–3317PubMedPubMedCentralCrossRef
51.
Malissen B, Tamoutounour S, Henri S (2014) The origins and functions of dendritic cells and macrophages in the skin. Nat Rev Immunol 14:417–428PubMedCrossRef
52.
Haniffa M, Shin A, Bigley V et al (2012) Human tissues contain CD141hi cross-presenting dendritic cells with functional homology to mouse CD103 + Nonlymphoid dendritic cells. Immunity 37:60–73PubMedPubMedCentralCrossRef
53.
Nakano H, Lin KL, Yanagita M et al (2009) Blood-derived inflammatory dendritic cells in lymph nodes stimulate acute TH1 immune responses. Nat Immunol 10:394–402PubMedPubMedCentralCrossRef
54.
Leon B, Martinez del Hoyo G, Parrillas V et al (2004) Dendritic cell differentiation potential of mouse monocytes: monocytes represent immediate precursors of CD8- and CD8+ splenic dendritic cells. Blood 103:2668–2676PubMedCrossRef
55.
Hohl TM, Rivera A, Lipuma L et al (2009) Inflammatory monocytes facilitate adaptive CD4 T cell responses during respiratory fungal infection. Cell Host Microbe 6:470–481PubMedPubMedCentralCrossRef
56.
Cheong C, Matos I, Choi J et al (2010) Microbial stimulation fully differentiates monocytes to DC-SIGN / CD209+ dendritic cells for immune T cell areas. Cell 143:416–429PubMedPubMedCentralCrossRef
57.
Chicha L (2004) Clonal type I interferon-producing and dendritic cell precursors are contained in both human lymphoid and myeloid progenitor populations. J Exp Med 200:1519–1524PubMedPubMedCentralCrossRef
58.
Manz MG, Traver D, Miyamoto T et al (2001) Dendritic cell potentials of early lymphoid and myeloid progenitors. Blood 97:3333–3341PubMedCrossRef
59.
Wu L, D’Amico A, Hochrein H et al (2001) Development of thymic and splenic dendritic cell populations from different hemopoietic precursors. Blood 98:3376–3382PubMedCrossRef
60.
Traver D, Akashi K, Manz M et al (2000) Development of CD8α-positive dendritic cells from a common myeloid progenitor. Science 290:2152–2154PubMedCrossRef
61.
Manz MG, Traver D, Akashi K et al (2001) Dendritic cell development from common myeloid progenitors. Ann N Y Acad Sci 938:167–173PubMedCrossRef
62.
Lyman SD, Jacobsen SE (1998) C-kit ligand and Flt3 ligand: stem/progenitor cell factors with overlapping yet distinct activities. Blood 91:1101–1134PubMed
63.
Onai N, Obata-Onai A, Schmid MA et al (2007) Identification of clonogenic common Flt3 + M-CSFR+ plasmacytoid and conventional dendritic cell progenitors in mouse bone marrow. Nat Immunol 8:1207–1216PubMedCrossRef
64.
Naik SH, Sathe P, Park H-Y et al (2007) Development of plasmacytoid and conventional dendritic cell subtypes from single precursor cells derived in vitro and in vivo. Nat Immunol 8:1217–1226PubMedCrossRef
65.
Karsunky H, Merad M, Cozzio A et al (2003) Flt3 ligand regulates dendritic cell development from Flt3+ lymphoid and myeloid-committed progenitors to Flt3+ dendritic cells in vivo. J Exp Med 198:305–313PubMedPubMedCentralCrossRef
66.
Waskow C, Liu K, Darrasse-jèze G et al (2008) FMS-like tyrosine kinase 3 is required for dendritic cell development in peripheral lymphoid tissues. Nat Immunol 9:676–683PubMedPubMedCentralCrossRef
67.
McKenna HJ (2001) Role of hematopoietic growth factors/flt3 ligand in expansion and regulation of dendritic cells. Curr Opin Hematol 8:149–154PubMedCrossRef
68.
Onai N, Obata-Onai A, Tussiwand R et al (2006) Activation of the Flt3 signal transduction cascade rescues and enhances type I interferon-producing and dendritic cell development. J Exp Med 203:227–238PubMedPubMedCentralCrossRef
69.
Fogg DK, Sibon C, Miled C et al (2006) A clonogenic bone marrow progenitor specific for macrophages and dendritic cells. Science 311:83–87PubMedCrossRef
70.
Merad M, Sathe P, Helft J et al (2013) The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu Rev Immunol 31:563–604PubMedCrossRef
71.
Bruno L, Seidl T, Lanzavecchia A (2001) Mouse pre-immunocytes as non-proliferating multipotent precursors of macrophages, interferon-producing cells, CD8α + and CD8α- dendritic cells. Eur J Immunol 31:3403–3412PubMedCrossRef
72.
73.
74.
Langlet C, Tamoutounour S, Henri S et al (2012) CD64 expression distinguishes monocyte-derived and conventional dendritic cells and reveals their distinct role during intramuscular immunization. J Immunol 188:1751–1760PubMedCrossRef
75.
Lewis KL, Caton ML, Bogunovic M et al (2011) Notch2 receptor signaling controls functional differentiation of dendritic cells in the spleen and intestine. Immunity 35:780–791PubMedPubMedCentralCrossRef
76.
77.
Hoeffel G, Wang Y, Greter M et al (2012) Adult Langerhans cells derive predominantly from embryonic fetal liver monocytes with a minor contribution of yolk sac-derived macrophages. J Exp Med 209:1167–1181PubMedPubMedCentralCrossRef
78.
79.
Ginhoux F, Collin MP, Bogunovic M et al (2007) Blood-derived dermal langerin + dendritic cells survey the skin in the steady state. J Exp Med 204:3133–3146PubMedPubMedCentralCrossRef
80.
Laouar Y, Welte T, Fu XY, Flavell RA (2003) STAT3 is required for Flt3L-dependent dendritic cell differentiation. Immunity 19:903–912PubMedCrossRef
81.
Lutz MB, Suri RM, Niimi M et al (2000) Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo. Eur J Immunol 30:1813–1822PubMedCrossRef
82.
Vremec D, J. Lieschke G, R. Dunn A, et al. (1997) The influence of granulocyte/macrophage colony-stimulating factor on dendritic cell levels in mouse lymphoid organs. Eur J Immunol 27:40–44.
83.
Hamilton JA (2008) Colony-stimulating factors in inflammation and autoimmunity. Nat Rev Immunol 8:533–544PubMedCrossRef
84.
Lyman SD, Jacobsen SEW (1998) C-kit ligand and Flt3 ligand: stem/progenitor cell factors with overlapping yet distinct activities. Blood 91:1101–1134PubMed
85.
Bozzacco L, Trumpfheller C, Huang Y et al (2010) HIV gag protein is efficiently cross-presented when targeted with an antibody towards the DEC-205 receptor in Flt3 ligand-mobilized murine DC. Eur J Immunol 40:36–46PubMedPubMedCentralCrossRef
86.
Dudziak D, Kampfhorst AO, Heidkamp G et al (2007) Differential antigen processing by dendritic cell subsets in vivo. Science 315:107–111PubMedCrossRef
87.
Tarbell KV, Petit L, Zuo X et al (2007) Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice. J Exp Med 204:191–201PubMedPubMedCentralCrossRef
88.
89.
Dhodapkar MV, Sznol M, Zhao B et al (2014) Induction of antigen-specific immunity with a vaccine targeting NY-ESO-1 to the dendritic cell receptor DEC-205. Sci Transl Med 6:232ra51PubMedCrossRef
90.
Spranger S, Bao R, Gajewski TF (2015) Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity. Nature 523:231–235PubMedCrossRef
91.
Salmon H, Idoyaga J, Rahman A et al (2016) Expansion and activation of CD103+ dendritic cell progenitors at the tumor site enhances tumor responses to therapeutic PD-L1 and BRAF inhibition. Immunity 44:924–938PubMedCrossRef
92.
Cisse B, Caton ML, Lehner M et al (2008) Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development. Cell 135:37–48PubMedPubMedCentralCrossRef
93.
Wu L, D’Amico A, Winkel KD et al (1998) RelB is essential for the development of myeloid-related CD8α- dendritic cells but not of lymphoid-related CD8α + dendritic cells. Immunity 9:839–847PubMedCrossRef
94.
Hildner K, Edelson BT, Purtha WE et al (2008) Batf3 deficiency reveals a critical role for CD8α + dendritic cells in cytotoxic T cell immunity. Science 322:1097–1100PubMedPubMedCentralCrossRef
95.
Anderson KL, Perkin H, Surh CD et al (2000) Transcription factor PU.1 is necessary for development of thymic and myeloid progenitor-derived dendritic cells. J Immunol 164:1855–1861PubMedCrossRef
96.
Spooner CJ, Cheng JX, Pujadas E et al (2009) A recurrent network involving the transcription factors PU.1 and Gfi1 orchestrates innate and adaptive immune cell fates. Immunity 31:576–586PubMedPubMedCentralCrossRef
97.
Rathinam C, Geffers R, Yucel R et al (2005) The transcriptional repressor Gfi1 controls STAT3-dependent dendritic cell development and function. Immunity 22:717–728PubMedCrossRef
98.
Satpathy AT, Kc W, Albring JC et al (2012) Zbtb46 expression distinguishes classical dendritic cells and their committed progenitors from other immune lineages. J Exp Med 209:1135–1152PubMedPubMedCentralCrossRef
99.
Meredith MM, Liu K, Darrasse-Jeze G et al (2012) Expression of the zinc finger transcription factor zDC (Zbtb46, Btbd4) defines the classical dendritic cell lineage. J Exp Med 209:1153–1165PubMedPubMedCentralCrossRef
100.
Ichikawa E, Hida S, Omatsu Y et al (2004) Defective development of splenic and epidermal CD4+ dendritic cells in mice deficient for IFN regulatory factor-2. Proc Natl Acad Sci U S A 101:3909–3914PubMedPubMedCentralCrossRef
101.
Suzuki S, Honma K, Matsuyama T et al (2004) Critical roles of interferon regulatory factor 4 in CD11bhighCD8alpha- dendritic cell development. Proc Natl Acad Sci U S A 101:8981–8986PubMedPubMedCentralCrossRef
102.
Tamura T, Tailor P, Yamaoka K et al (2005) IFN regulatory factor-4 and -8 govern dendritic cell subset development and their functional diversity. J Immunol 174:2573–2581PubMedCrossRef
103.
Schiavoni G, Mattei F, Borghi P et al (2004) ICSBP is critically involved in the normal development and trafficking of Langerhans cells and dermal dendritic cells. Blood 103:2221–2228PubMedCrossRef
104.
Aliberti J, Schulz O, Pennington DJ et al (2003) Essential role for ICSBP in the in vivo development of murine CD8α + dendritic cells. Blood 101:305–310PubMedCrossRef
105.
106.
Hacker C, Kirsch RD, Ju X-S et al (2003) Transcriptional profiling identifies Id2 function in dendritic cell development. Nat Immunol 4:380–386PubMedCrossRef
107.
Nagasawa M, Schmidlin H, Hazekamp MG et al (2008) Development of human plasmacytoid dendritic cells depends on the combined action of the basic helix-loop-helix factor E2-2 and the Ets factor Spi-B. Eur J Immunol 38:2389–2400PubMedCrossRef
108.
Edelson BT, Kc W, Juang R et al (2010) Peripheral CD103+ dendritic cells form a unified subset developmentally related to CD8alpha + conventional dendritic cells. J Exp Med 207:823–836PubMedPubMedCentralCrossRef
109.
Fainaru O, Woolf E, Lotem J et al (2004) Runx3 regulates mouse TGF-beta-mediated dendritic cell function and its absence results in airway inflammation. EMBO J 23:969–979PubMedPubMedCentralCrossRef
110.
Esashi E, Wang YH, Perng O et al (2008) The signal transducer STAT5 inhibits plasmacytoid dendritic cell development by suppressing transcription factor IRF8. Immunity 28:509–520PubMedPubMedCentralCrossRef
111.
112.
Wu L, Nichogiannopoulou A, Shortman K, Georgopoulos K (1997) Cell-autonomous defects in dendritic cell populations of Ikaros mutant mice point to a developmental relationship with the lymphoid lineage. Immunity 7:483–492PubMedCrossRef
113.
114.
Jackson JT, Hu Y, Liu R et al (2011) Id2 expression delineates differential checkpoints in the genetic program of CD8alpha + and CD103+ dendritic cell lineages. EMBO J 30:2690–2704PubMedPubMedCentralCrossRef
115.
Platzer B, Jörgl A, Taschner S et al (2004) RelB regulates human dendritic cell subset development by promoting monocyte intermediates. Blood 104:3655–3663PubMedCrossRef
116.
Kingston D, Schmid MA, Onai N et al (2009) The concerted action of GM-CSF and Flt3-ligand on in vivo dendritic cell homeostasis. Blood 114:835–843PubMedCrossRef
117.
Greter M, Helft J, Chow A et al (2012) GM-CSF controls nonlymphoid tissue dendritic cell homeostasis but is dispensable for the differentiation of inflammatory dendritic cells. Immunity 36:1031–1046PubMedPubMedCentralCrossRef
118.
Kel JM, Girard-Madoux MJH, Reizis B, Clausen BE (2010) TGF-β is required to maintain the pool of immature langerhans cells in the epidermis. J Immunol 185:3248–3255PubMedCrossRef
119.
Wang Y-G, Kim KD, Wang J et al (2005) Stimulating lymphotoxin beta receptor on the dendritic cells is critical for their homeostasis and expansion. J Immunol 175:6997–7002PubMedCrossRef
120.
Wu Q, Wang Y, Wang J et al (1999) The requirement of membrane lymphotoxin for the presence of dendritic cells in lymphoid tissues. J Exp Med 190:629–638PubMedPubMedCentralCrossRef
121.
Qian C, Qian L, Yu Y et al (2013) Fas signal promotes the immunosuppressive function of regulatory dendritic cells via the ERK/β-catenin pathway. J Biol Chem 288:27825–27835PubMedPubMedCentralCrossRef
122.
Bonasio R, Scimone ML, Schaerli P et al (2006) Clonal deletion of thymocytes by circulating dendritic cells homing to the thymus. Nat Immunol 7:1092–1100PubMedCrossRef
123.
Proietto AI, van Dommelen S, Zhou P et al (2008) Dendritic cells in the thymus contribute to T-regulatory cell induction. Proc Natl Acad Sci U S A 105:19869–19874PubMedPubMedCentralCrossRef
124.
Watanabe N, Wang Y-H, Lee HK et al (2005) Hassall’s corpuscles instruct dendritic cells to induce CD4 + CD25+ regulatory T cells in human thymus. Nature 436:1181–1185PubMedCrossRef
125.
Besin G, Gaudreau S, Menard M et al (2008) Thymic stromal lymphopoietin and thymic stromal lymphopoietin-conditioned dendritic cells induce regulatory T-cell differentiation and protection of NOD mice against diabetes. Diabetes 57:2107–2117PubMedPubMedCentralCrossRef
126.
Martin-Gayo E, Sierra-Filardi E, Corbi AL, Toribio ML (2010) Plasmacytoid dendritic cells resident in human thymus drive natural Treg cell development. Blood 115:5366–5375PubMedCrossRef
127.
128.
Ardouin L, Luche H, Chelbi R et al (2016) Broad and largely concordant molecular changes characterize tolerogenic and immunogenic dendritic cell maturation in thymus and periphery. Immunity 45:305–318PubMedCrossRef
129.
McGrath MM, Najafian N (2012) The role of coinhibitory signaling pathways in transplantation and tolerance. Front Immunol 3:1–17CrossRef
130.
Yang J, Riella LV, Chock S et al (2011) The novel costimulatory programmed death ligand 1/B7.1 pathway is functional in inhibiting alloimmune responses in vivo. J Immunol 187:1113–1119PubMedPubMedCentralCrossRef
131.
Li H, Shi B (2015) Tolerogenic dendritic cells and their applications in transplantation. Cell Mol Immunol 12:24–30PubMedCrossRef
132.
Morelli AE, Thomson AW (2003) Dendritic cells: regulators of alloimmunity and opportunities for tolerance induction. Immunol Rev 196:125–146PubMedCrossRef
133.
Munn DH, Sharma MD, Mellor AL (2004) Ligation of B7-1/B7-2 by human CD4+ T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells. J Immunol 172:4100–4110PubMedCrossRef
134.
Grohmann U, Orabona C, Fallarino F et al (2002) CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat Immunol 3:1097–1101PubMedCrossRef
135.
Mellor AL, Munn DH (2004) IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol 4:762–774PubMedCrossRef
136.
Jürgens B, Hainz U, Fuchs D et al (2009) Interferon-γ-triggered indoleamine2,3-dioxygenase competence in human monocyte-derived dendritic cells induces regulatory activity in allogeneic T cells. Blood 114:3235–3243PubMedCrossRef
137.
Grohmann U, Puccetti P (2002) The immunosuppressive activity of proinflammatory cytokines in experimental models : potential for therapeutic intervention in autoimmunity. Curr Drug Targets Inflamm Allergy 1:77–87PubMedCrossRef
138.
Brenk M, Scheler M, Koch S et al (2009) Tryptophan deprivation induces inhibitory receptors ILT3 and ILT4 on dendritic cells favoring the induction of human CD4 + CD25+ Foxp3+ T regulatory cells. J Immunol 183:145–154PubMedCrossRef
139.
Chauveau C, Rémy S, Royer PJ et al (2005) Heme oxygenase-1 expression inhibits dendritic cell maturation and proinflammatory function but conserves IL-10 expression. Blood 106:1694–1702PubMedCrossRef
140.
Yamashita K, Ollinger R, McDaid J et al (2006) Heme oxygenase-1 is essential for and promotes tolerance to transplanted organs. FASEB J 20:776–778PubMed
141.
Luckashenak N, Schroeder S, Endt K et al (2008) Constitutive crosspresentation of tissue antigens by dendritic cells controls CD8+ T cell tolerance in vivo. Immunity 28:521–532PubMedCrossRef
142.
Bonifaz L, Bonnyay D, Mahnke K et al (2002) Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J Exp Med 196:1627–1638PubMedPubMedCentralCrossRef
143.
Belz GT, Behrens GMN, Smith CM et al (2002) The CD8 + dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens. J Exp Med 196:1099–1104PubMedPubMedCentralCrossRef
144.
Segura E, Amigorena S (2015) Cross-Presentation in Mouse and Human Dendritic Cells, 1st ed. Adv Immunol
145.
Bedoui S, Whitney PG, Waithman J et al (2009) Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells. Nat Immunol 10:488–495PubMedCrossRef
146.
del Rio M-L, Rodriguez-Barbosa J-I, Kremmer E, Förster R (2007) CD103− and CD103+ bronchial lymph node dendritic cells are specialized in presenting and cross-presenting innocuous antigen to CD4+ and CD8+ T cells. J Immunol 178:6861–6866PubMedCrossRef
147.
Amigorena S, Savina A (2010) Intracellular mechanisms of antigen cross presentation in dendritic cells. Curr Opin Immunol 22:109–117PubMedCrossRef
148.
Lennon-Duménil A-M, Bakker AH, Maehr R et al (2002) Analysis of protease activity in live antigen-presenting cells shows regulation of the phagosomal proteolytic contents during dendritic cell activation. J Exp Med 196:529–540PubMedPubMedCentralCrossRef
149.
Trombetta ES, Ebersold M, Garrett MP, Mellman I (2003) Activation of lysosomal function during dendritic cell maturation. Science 299:1400–1403PubMedCrossRef
150.
Savina A, Jancic C, Hugues S et al (2006) NOX2 controls phagosomal pH to regulate antigen processing during crosspresentation by dendritic cells. Cell 126:205–218PubMedCrossRef
151.
152.
Kim JM, Kim JM, Rudensky A, Rudensky A (2006) The role of the transcription factor Foxp3 in the development of regulatory T cells. Immunol Rev 212:86–98PubMedCrossRef
153.
Vigouroux S, Yvon E, Biagi E, Brenner MK (2004) Antigen-induced regulatory T cells. Blood 104:26–33PubMedCrossRef
154.
155.
156.
Ostroukhova M, Seguin-devaux C, Oriss TB et al (2004) Tolerance induced by inhaled antigen involves CD4 + T cells expressing membrane-bound TGF-β and FOXP3. J Clin Invest 114:28–38PubMedPubMedCentralCrossRef
157.
Tsuji NM, Kosaka A (2008) Oral tolerance: intestinal homeostasis and antigen-specific regulatory T cells. Trends Immunol 29:532–540PubMedCrossRef
158.
Cronin SJF, Penninger JM (2007) From T-cell activation signals to signaling control of anti-cancer immunity. Immunol Rev 220:151–168PubMedCrossRef
159.
Tisch R (2010) Immunogenic versus tolerogenic dendritic cells: a matter of maturation. Int Rev Immunol 29:111–118PubMedCrossRef
160.
Hintzen G, Ohl L, del Rio M-L et al (2006) Induction of tolerance to innocuous inhaled antigen relies on a CCR7-dependent dendritic cell-mediated antigen transport to the bronchial lymph node. J Immunol 177:7346–7354PubMedCrossRef
161.
Worbs T, Bode U, Yan S et al (2006) Oral tolerance originates in the intestinal immune system and relies on antigen carriage by dendritic cells. J Exp Med 203:519–527PubMedPubMedCentralCrossRef
162.
Förster R, Davalos-Misslitz AC, Rot A (2008) CCR7 and its ligands: balancing immunity and tolerance. Nat Rev Immunol 8:362–371PubMedCrossRef
163.
Langenkamp A, Messi M, Lanzavecchia A, Sallusto F (2000) Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells. Nat Immunol 1:311–316PubMedCrossRef
164.
Langenkamp A, Casorati G, Garavaglia C et al (2002) T cell priming by dendritic cells: thresholds for proliferation, differentiation and death and intraclonal functional diversification. Eur J Immunol 32:2046–2054PubMedCrossRef
165.
Croker BA, Krebs DL, Zhang J-G et al (2003) SOCS3 negatively regulates IL-6 signaling in vivo. Nat Immunol 4:540–545PubMedCrossRef
166.
Pasare C, Medzhitov R (2003) Toll pathway-dependent blockade of CD4 + CD25+ T cell-mediated suppression by dendritic cells. Science 299:1033–1036PubMedCrossRef
167.
Veillette A, Latour S (2003) The SLAM family of immune-cell receptors. Curr Opin Immunol 15:277–285PubMedCrossRef
168.
Dennis KL, Blatner NR, Gounari F, Khazaie K (2013) Current status of interleukin-10 and regulatory T-cells in cancer. Curr Opin Oncol 25:637–645PubMedPubMedCentralCrossRef
169.
Ohnmacht C, Pullner A, King SBS et al (2009) Constitutive ablation of dendritic cells breaks self-tolerance of CD4 T cells and results in spontaneous fatal autoimmunity. J Exp Med 206:549–559PubMedPubMedCentralCrossRef
170.
Laouar Y, Town T, Jeng D et al (2008) TGF-beta signaling in dendritic cells is a prerequisite for the control of autoimmune encephalomyelitis. Proc Natl Acad Sci U S A 105:10865–10870PubMedPubMedCentralCrossRef
171.
Travis MA, Reizis B, Melton AC et al (2007) Loss of integrin αvβ8 on dendritic cells causes autoimmunity and colitis in mice. Nature 449:361–365PubMedPubMedCentralCrossRef
172.
Darrasse-Jeze G, Deroubaix S, Mouquet H et al (2009) Feedback control of regulatory T cell homeostasis by dendritic cells in vivo. J Exp Med 206:1853–1862PubMedPubMedCentralCrossRef
173.
Volchenkov R, Karlsen M, Jonsson R, Appel S (2013) Type 1 regulatory T cells and regulatory B cells induced by tolerogenic dendritic cells. Scand J Immunol 77:246–254PubMedCrossRef
174.
175.
Qian L, Qian C, Chen Y et al (2012) Regulatory dendritic cells program B cells to differentiate into CD19hiFcγIIbhi regulatory B cells through IFN-β and CD40L. Blood 120:581–591PubMedCrossRef
176.
Obayashi K, Doi T, Koyasu S (2007) Dendritic cells suppress IgE production in B cells. Int Immunol 19:217–226PubMedCrossRef
177.
Caielli S, Conforti-Andreoni C, Di Pietro C et al (2010) On/off TLR signaling decides proinflammatory or tolerogenic dendritic cell maturation upon CD1d-mediated interaction with invariant NKT cells. J Immunol 185:7317–7329PubMedCrossRef
178.
179.
Leveson-Gower DB, Sega EI, Kalesnikoff J et al (2013) Mast cells suppress murine GVHD in a mechanism independent of CD4 + CD25+ regulatory T cells. Blood 122:3659–3665PubMedPubMedCentralCrossRef
180.
Lu L-F, Lind EF, Gondek DC et al (2006) Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 442:997–1002PubMedCrossRef
181.
Rodrigues CP, Ferreira ACF, Pinho MP et al (2016) Tolerogenic IDO(+) dendritic cells are induced by PD-1-expressing mast cells. Front Immunol 7:9PubMedPubMedCentralCrossRef
182.
Ito K, Chung KF, Adcock IM (2006) Update on glucocorticoid action and resistance. J Allergy Clin Immunol 117:522–543PubMedCrossRef
183.
Puccetti P, Grohmann U (2007) IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-kappaB activation. Nat Rev Immunol 7:817–823PubMedCrossRef
184.
Bonizzi G, Karin M (2004) The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol 25:280–288PubMedCrossRef
185.
Zhang X, Li M, Lian D et al (2008) Generation of therapeutic dendritic cells and regulatory T cells for preventing allogeneic cardiac graft rejection. Clin Immunol 127:313–321PubMedCrossRef
186.
Iruretagoyena MI, Lezana JP, Hermoso M et al (2006) Inhibition of nuclear factor-kappa B enhances the capacity of immature dendritic cells to induce antigen-specific tolerance in experimental autoimmune encephalomyelitis. J Pharmacol Exp Ther 318:59–67PubMedCrossRef
187.
Bahri R, Naji A, Menier C et al (2009) Dendritic cells secrete the immunosuppressive HLA-G molecule upon CTLA4-Ig treatment: implication in human renal transplant acceptance. J Immunol 183:7054–7062PubMedCrossRef
188.
Hu J, Wan Y (2010) Tolerogenic dendritic cells and their potential applications. Immunology 132:307–314CrossRef
189.
Anandasabapathy N, Breton G, Hurley A et al (2015) Efficacy and safety of CDX-301, recombinant human Flt3L, at expanding dendritic cells and hematopoietic stem cells in healthy human volunteers. Bone Marrow Transplant 50:924–930PubMedPubMedCentralCrossRef
190.
He S, Chu J, Vasu S et al (2014) FLT3L and plerixafor combination increases hematopoietic stem cell mobilization and leads to improved transplantation outcome. Biol Blood Marrow Transplant 20:309–313PubMedCrossRef
Metadaten
Titel
The origin of DCs and capacity for immunologic tolerance in central and peripheral tissues
verfasst von
K . Sanjana P. Devi
Niroshana Anandasabapathy
Publikationsdatum
25.11.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Seminars in Immunopathology / Ausgabe 2/2017
Print ISSN: 1863-2297
Elektronische ISSN: 1863-2300
DOI
https://doi.org/10.1007/s00281-016-0602-0

Weitere Artikel der Ausgabe 2/2017

Seminars in Immunopathology 2/2017 Zur Ausgabe

Review

Dendritic cells and parasites: from recognition and activation to immune response instruction

Review

Dendritic cells in central nervous system autoimmunity

Review

Dendritic cells as gatekeepers of tolerance

Review

Tolerogenic dendritic cells

Review

The development of dendritic cell vaccine-based immunotherapies for glioblastoma

Introduction

Dendritic cells in autoimmunity, infections, and cancer

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 | Hypertonie | Nachrichten

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 | Parkinson-Krankheit | Nachrichten

Viel Bewegung in der Parkinsonforschung

25.04.2024 | Nierenkarzinom | Nachrichten

Adjuvante Immuntherapie verlängert Leben bei RCC
weitere anzeigen

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise